LL-49F233alpha, a novel antibiotic produced by an unknown fungus: biological and mechanistic activities.
Singh
M P
MP
Natural Products Microbiology, Wyeth-Ayerst Research, Pearl River, NY 10965, USA.
Zaccardi
J
J
Greenstein
M
M
D000900:Anti-Bacterial Agents / Q000096:biosynthesis / Q000737:chemistry / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000096:biosynthesis; D004269:DNA, Bacterial / Q000096:biosynthesis; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects / Q000378:metabolism; D005658:Fungi / Q000378:metabolism; D006090:Gram-Negative Bacteria / Q000187:drug effects; D006094:Gram-Positive Bacteria / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D015394:Molecular Structure; D009281:Naphthalenes / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D011188:Potassium / Q000378:metabolism; D011758:Pyrroles / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D012329:RNA, Bacterial / Q000096:biosynthesis
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D004269:DNA, Bacterial; C117824:LL 49F233alpha; D009281:Naphthalenes; D011758:Pyrroles; D012329:RNA, Bacterial; D011188:Potassium